NDC 68788-9809-01 - LISINOPRIL AND HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-9809
- Requested NDC
- 68788-9809-01
- Package NDCs from labels
- 68788-9809-3, 68788-9809-6, 68788-9809-9, 68788-9809-1, 68788-9809-01
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Effective date
- 2026-05-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS USP | Preferred Pharmaceuticals, Inc. | 2026-05-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-9809-1 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 100 in 1 BOTTLE | TABLET | 100 | 13 | |
| 68788-9809-3 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET | 30 | 13 | |
| 68788-9809-6 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 60 in 1 BOTTLE | TABLET | 60 | 13 | |
| 68788-9809-9 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET | 90 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-9809 | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.] | 11 | Current NDC, Legacy NDC, 4 package rows | 20240621_5aa18b0b-4688-493a-a5ae-cb056ea6c0e3.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ferrum rosatum Graphites | FERRUM ROSATUM GRAPHITES | Uriel Pharmacy Inc. | 1a4ca338-eada-4c0f-8bce-480244940c89 | 2025-06-27 | Warnings | 1K09F3G675 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 8d5a9196-5f1d-2d83-e053-2a95a90a6036 | 2025-06-27 | Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | d5387b26-90a3-44f0-850b-8aa1219fd26b | 2025-06-26 | Warnings, Adverse reactions | 0J48LPH2TH |
| losartan potassium and hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | eb423f4b-8104-4406-bfc2-8943e517329f | 2025-06-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | ca1a0aac-d81d-4c0a-91ea-cb719af772bf | 2025-06-25 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | A-S Medication Solutions | d81deeaf-7e5e-44c5-9348-5923c4e3ccd6 | 2025-06-19 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 5c4c5907-36f0-461e-b0c9-d51edff32a97 | 2025-06-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | American Health Packaging | 13ed002f-c5bb-401c-891a-70b70cbd8fb6 | 2025-06-18 | Warnings, Adverse reactions | 0J48LPH2TH |
| Benazepril Hydrochloride and Hydrochlorothiazide | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | Sandoz Inc | c9bdfbb4-87b6-4de4-bc1d-5025d3ef591f | 2025-06-14 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Unichem Pharmaceuticals (USA), Inc. | 33f3b980-b339-4dbf-99bd-05588c2a298c | 2025-06-13 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 352061ee-942d-6cba-e063-6294a90a9eea | 2025-06-13 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | f7415f1d-98c7-454f-bb1a-f59e95652c88 | 2025-06-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Aquavit | AQUAVIT | Uriel Pharmacy Inc. | c1c0887a-c388-c737-e053-2a95a90a076c | 2025-06-06 | Warnings | 1K09F3G675 |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 794d4a5a-de31-4878-95d5-23552dd2171e | 2025-06-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 744c1785-42b2-46a5-b0f4-2887a9ec2051 | 2025-06-03 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | e9ecbadb-c548-6fe5-e053-2a95a90a7577 | 2025-06-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | f1df0d1e-d418-4f6e-a04a-77b5d4000e2b | 2025-06-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | c59c4230-7cea-4259-9f2f-6a568716fedf | 2025-06-02 | Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 8d3e9c30-8dcf-491a-a515-6890b391398e | 2025-05-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | d55b2f01-5cd1-40bb-8d36-34b5b9081ddc | 2025-05-29 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.